Prostate cancer active surveillance does not up metastasis risk

Active surveillance for low-risk prostate cancer is not associated with a higher rate of metastatic disease after 15 years of follow-up, in a study comparing radiotherapy treatments and radical prostatectomy.
Renal and Urology News